Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: khrnyc who wrote (2196)	2/2/1998 10:35:00 PM
From: Bill Wexler	Read Replies (1) \| Respond to of 7041

Hi Keith, let's consider a much more important question: a) You claim that you're a physician - you even pretentiously put the "MD" after your username on Silicon Investor. b) You claim that you also do biotech investment consulting - so we may assume that you understand the stock market and biotech companies in general. c) You claim that after "due diligence", you ponied up your own money to buy Zonagen stock. YET YOU DIDN'T KNOW THAT ZONAGEN'S VASOMAX WAS A PILL THAT WAS SWALLOWED UNTIL AFTER SEVERAL DAYS OF POSTING HERE. Message 3238450 Now why is that Keith? Judging from your last post, I take it that you have decided to drop the facade of an informed, wise physician and have reverted to your true form: a loathsome shill spreading lies about this worthless, crooked company. Congratulations.

To: khrnyc who wrote (2196)	2/3/1998 9:54:00 PM
From: Dauntless	Read Replies (1) \| Respond to of 7041

Dr. Rubin, Hi, I've enjoyed reading your posts. Another FACT or two to add to your analysis of the recent stock price is the general decline of the biotech stocks over the period of interest. If you plot the biotech index for this period, you will see that there has been an 18% - 20% decline (excluding the last day or so). Additionally, this is not the first time Zonagen (or most development stage pharmaceutical companies) has shown this sort of volatility. I believe that Zonagen fell from around 19 to 7 or so a couple of years ago. The truth is that the potential earnings leverage from just a single successful drug for a low burn rate company like Zonagen is phenomenal. That's why they have such great swings. The final act will depend mostly on the FDA, the patent office and SGP - IMHO.